Company intelligence / Profile preview

Meghmani Lifesciences

Ahmedabad, Gujarat, India

Ownership: Private
Development stage: Other

Overview

Meghmani Lifesciences is an Indian pharmaceutical company and a subsidiary of the Meghmani Group, one of India's largest manufacturers of Paracetamol. The company focuses on developing, manufacturing, and marketing a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its therapeutic areas of focus include respiratory health (allergic rhinitis, asthma), neuropathy (neuropathic pain), anti-inflammatories, and nutraceuticals. Meghmani Lifesciences is committed to delivering high-quality, innovative medicines to improve patient well-being across India and global markets.

Therapeutic areas: PulmonologyImmunologyDermatologyNeurologyEndocrinologyMetabolic Disorders
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Meghmani Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meghmani Lifesciences.

Explore the full profile